Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Ferrante M, Khan A, Fan C, Jelloul FZ. Schwannoma of the cervical esophagus. Rare Tumors. 2014;6(2):5361.

Vogel MJ, Xie L, Guan H, Tooze RM, Maier T, Kostezka U, et al. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. Blood. 2014;124(20):3118-29.

Garner O, Mochon A, Branda J, Burnham C-, Bythrow M, Ferraro M, et al. Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK® MS system. Clin Microbiol Infect. 2014;20(4):335-9.

Bashir S, Jiang G, Joshi A, Miller C, Matrai C, Yemelyanova A, et al. Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors. Int J Gynecol Cancer. 2014;24(7):1262-7.

Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, et al. 5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer. JAMA Intern Med. 2014;174(8):1301-7.

Aldi S, Robador PA, Tomita K, Di Lorenzo A, Levi R. IgE receptor-mediated mast-cell renin release. Am J Pathol. 2014;184(2):376-81.

Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, et al. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 2014;25(5):652-65.

Ellis JA, Gill BJ, Pisapia D, Winfree CJ. Superficial temporal artery pseudoaneurysm following trigeminal nerve stimulator placement. Neuromodulation. 2014;17(8):788-90.

Gill K, Ariyan C, Wang X, Brady MS, Pulitzer M. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression. J Surg Oncol. 2014;110(3):258-64.

Arruga F, Gizdic B, Serra S, Vaisitti T, Ciardullo C, Coscia M, et al. Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. Leukemia. 2014;28(5):1060-70.